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Abstract
Background: To explore folk understandings of blood borne virus infection and infectiousness
among injecting drug users in Kings Cross, Sydney.
Methods: Observational fieldwork was conducted in Kings Cross over a four month period. In-
depth interviews with 24 current injectors and 4 key informants recruited from King Cross were
undertaken.
Results: Hepatitis C (HCV) generated different meanings from HIV. HIV was considered "the
dreaded" and generated fear of infection and dire disease progression. Whereas HCV was
considered non-desirable but less threatening than HIV. The risks of transmitting HCV through
sharing injecting paraphernalia was poorly understood. Some believed HCV infection was linked to
poor hygiene and dirty water. Jaundice was mistakenly thought to indicate HCV infection and was
used to gauge infectiousness. Many were confused about their current hepatitis C serostatus. Some
participants thought they had a "dormant antibody" or that they had a "mild case" of infection.
Participants were unsure what this meant for their own health or for their potential to infect
others.
Conclusion: Participants displayed confusion about transmission risks for hepatitis C, conflating
blood awareness and hygiene health promotion messages. Participants' reliance on the symptom of
jaundice to gauge serostatus places them at risk of transmitting and contracting HCV. Participants
were confused about what a positive HCV diagnosis meant for their own health and their ability to
infect others. Education is needed to debunk misconceptions about jaundice and clarify medical
terms such as 'antibody' at the time of diagnosis. Further clarification of messages about injecting
hygiene and blood awareness are also required.
Introduction
An estimated 210,000 people are living with the hepatitis
C virus (HCV) in Australia [1]. HCV is transmitted mainly
through the shared use of injecting equipment by inject-
ing drug users (IDUs) [2,3]. HCV is the most prevalent
blood-borne virus infection among Australian IDUs, var-
ying from almost 90% to just under 50%, depending on
the injecting population sampled [4-7]. HCV infection is
a major public health concern. High prevalence combined
with high rates of new infection, continue to result in a
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large number of chronically ill people, a percentage of
whom will develop cirrhosis of the liver and hepatocellu-
lar carcinoma [8,9]. Moreover, the potential cumulative
health care costs of HCV infection over the next 60 years
will be approximately $4 billion [10].
Epidemiological and quantitative behavioural research on
hepatitis C has concentrated on documenting risk behav-
iour and knowledge of hepatitis C transmission risks
among injecting drug users [2,3,7,11,12]. Qualitative
research has sought to contextualise risk behaviour,
enhancing the findings from quantitative studies [13-15].
Few studies have sought to uncover the ways IDUs them-
selves make sense of the medical terms and clinical mark-
ers associated with hepatitis C [16]. This includes the way
injectors differentiate between blood-borne viruses; folk
interpretations of medical terms and the symptoms of dis-
ease; and the links between these lay understandings and
risky injecting. This article explores, using qualitative data,
folk understandings of the hepatitis C virus among a
group of IDUs who live in or frequently visit Kings Cross,
Sydney.
The research utilised a socio-cultural approach to docu-
menting and interpreting risky injecting practice [17-19].
It aimed to provide a window into the world of marginal-
ised injecting drug users [20]. It sought not only to meas-
ure injectors' knowledge of hepatitis C against an expert
standard of "right or wrong" fact, but also to reveal injec-
tors' understandings of the virus as a real and threatening
entity in their everyday lives. The significance of the
approach lies in its ability to reveal interfaces between lay
and expert knowledge: injectors take up the clinical lan-
guage of medicine and health promotion and actively use
it to make sense of living with HCV and to assess the like-
lihood of infecting others. The research therefore informs
prevention efforts and education initiatives devised to
inform people of the implications of their HCV status.
Method
Site selection
The study took place in Kings Cross, Sydney, between July
2001 and February 2002. Kings Cross is home to a
dynamic, open-air drug market and a "red light" district.
The drug market offers opportunities for small and large
scale drug dealing in heroin, and more recently, cocaine.
A range of other drugs such as ecstasy, amphetamine and
methamphetamine are also available. Kings Cross pro-
vides an interesting site for the study of injecting networks
for several reasons. The dynamic, open-air nature of the
drug market facilitates aspects of qualitative field work
including observation of public injecting and a height-
ened awareness of issues among health workers (which in
turn translates into research questions). Kings Cross is the
home of numerous health and welfare services, many of
which target IDUs. No other area in Australia has so many
services targeting IDUs, coupled with the long history of
health initiatives aimed at preventing blood-borne virus
infection (BBVI) transmission since the arrival of HIV in
the mid 1980s. This study posed questions regarding the
continuation of risk practice in an environment where
free, sterile injecting equipment is readily available and
education about BBVI transmission is constantly being
delivered by health care workers.
Data sources and sample
Three methods were used for data collection. Firstly, on-
going contact with four key informants, including a local
"guide" who was familiar with multiple injecting net-
works, provided continuous information on the state of
the Kings Cross drug market and its impact on risk prac-
tice. Key informants were chosen because they were con-
sidered opinion leaders in their injecting network [21]. To
facilitate field work, the research team asked service pro-
viders to nominate a guide [22]. The guide escorted the
researcher through a variety of injecting locations, intro-
duced the researcher to local identities and assisted in the
selection of participants for in-depth interviews. The guide
and other key informants helped to verify the accuracy of
information as it emerged during the course of the study.
Conversations with key informants were recorded in field
note form.
Secondly, observational fieldwork was conducted
between November 2001-February 2002. Approximately
300 hours were spent in the field. Fieldwork involved
mapping the range of public, semi-public and private
injecting locations in Kings Cross. Mapping of physical
locations was complemented by the identification of net-
works of injecting drug users who frequented these sites.
Limited observations of in-situ injecting episodes also
occurred. Observations were recorded in field note form.
Thirdly, in-depth semi-structured interviews were con-
ducted with IDUs living in or visiting the Kings Cross area.
An interview schedule guided the process. The schedule
was developed collaboratively by the investigators and
key informants. The schedule comprised questions on
drug use history, current injecting practice, BBVI knowl-
edge and risk scenarios. Over three quarters of interview
participants were recruited through the guide or by chain
referral (snowballing). Interviews were conducted in a
rented room at a welfare agency, in cafes and in public
locations. Interviews lasted between thirty and ninety
minutes.
Ethics approval was obtained from the University of New
South Wales Human Research Ethics Committee.
Informed written consent was obtained for interviews.
Participants received up to $30 (Aus) as reimbursementInternational Journal for Equity in Health 2005, 4:5 http://www.equityhealthj.com/content/4/1/5
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for their time. The guide was employed at casual research
officer rates.
In all, twenty four interviews were conducted, fourteen
with men and ten with women. Ages ranged from 19 to 47
with most interviewees in their thirties. One participant
was HIV positive. It was difficult to assess, on self-report,
the HCV status of participants as there was confusion
regarding current status, although most believed them-
selves to have been infected at some time. Participants pri-
marily injected heroin, with most injecting cocaine when
it was available. Few participants had stable housing,
however most were homeless or itinerant, their lives char-
acterised by social marginalisation, poverty and extreme
poor health.
Analysis
In line with Smith [23] and Glaser and Strauss [24], field
notes and interview data were analysed in an on-going
manner. Interviews and field notes were coded for key
words, themes, issues and events. These were compared,
contrasted and synthesised to create a system of thematic
classification. A number of processes were used to assess
the validity of the analysis. First, the research team read all
the transcripts and field notes and analysed these data for
contexts for BBVIs transmission as identified in the litera-
ture; common concerns of and discourses used by partici-
pants; similarities and disparities in network membership
and environmental location for injecting; and collective
and individual patterns of social action that make up eve-
ryday life. Data were re-read for disconfirming evidence. A
process of theoretical validity was undertaken to ensure
that the units of classification (themes, issues, concepts)
were sensitive to the accounts supplied by participants
and to scholarly literature [25]. Theoretical validity
extended to evaluating the internal logic of and relation-
ships between units of analysis [26]. Validity involved the
use of a collective process of checking, questioning and
theorising [27].
Results
Mixing messages: Folk understandings of 'Blood 
Awareness' and Hygiene Health Promotion messages
For most participants, HCV generated significantly differ-
ent meanings from HIV. HIV was colloquially referred to
as "the dreaded", a term encapsulating fear of infection
and dire disease progression. HIV elicited strong reac-
tions, in particular the desire to prevent infection by
avoiding certain types of injectors considered to be at high
risk such as gay men, or those individuals 'known' to be
infected with the virus. In contrast to HIV, the meanings
attached to the hepatitis C virus were fairly diverse. While
hepatitis C infection was not considered desirable, partic-
ipants viewed HCV as less damaging to health and quality
of life than HIV. However, there was little evidence of a
forlorn fatalism in regard to HCV infection: it was not
considered attractive or inevitable. Nor was it viewed as a
'badge' signifying the position of a 'real user' contrary to
previous research [28]. Pragmatism rather than fatalism
predominated: if participants could avoid sharing needles
(needle-sharing being the focus of folk infection-control)
then they would. In cases where circumstances were
deemed to prevent safer use then risks would be taken.
The concentration on preventing needle-sharing reflected
the success of earlier HIV prevention campaigns based on
the 'new fit for every hit' message. Some participants had
good knowledge of 'blood awareness' health promotion
messages, that is of the risks associated with transmitting
HCV via the use of blood contaminated injecting para-
phernalia and through touching others with bloody fin-
gers etc. About half of the participants were less cognisant
of these means of transmission.
Indeed, a number of participants held the view that hepa-
titis C was transmitted "through dirt". In many cases par-
ticipants were re-interpreting public health hygiene
messages. These messages refer to the benefits of hand-
washing and wiping surfaces after injecting to prevent the
inadvertent spread of HCV via touch and environmental
blood transmission. HCV transmission was associated as
much with unhygienic practice and "dirty, desperate" peo-
ple as it was with technical blood-to-blood transmission
routes [29]. Some participants, like Bruce, provided expla-
nations for contracting HCV which involved both hygiene
and blood awareness messages:
Well I'm hep C positive at the moment and have been for quite
a long time and I think that came about when I wasn't using
sterile injecting water. I was taking water out of the toilets and
things like that and using that to inject and I think that's how
I got hep C. [Interviewer: So it wasn't sharing needles with
other people?] No. It could have been either that or finding
somebody else's blood or something in one of the packets (con-
taining a drug deal) or something and just continuing to have
what was left of the packet or something like that that caused
me to get it. Or it could have been just using a very, very old
syringe where the blood had gone off or something. (Bruce, a
30 year old injector).
Bruce's account is indicative of the way participants asso-
ciated HCV transmission with both unhygienic practice
and scientifically known transmission routes. Bruce vari-
ously suggests he may have contracted HCV from toilet
water; from blood left in an old deal packet (one assumes
a small plastic bag); or from re-using a "very, very, old
syringe". Bruce demonstrates good technical knowledge
when he states that HCV can be transmitted through
blood contamination in drug deal packets. He also exhib-
its a commonly held understanding that HCV transmis-International Journal for Equity in Health 2005, 4:5 http://www.equityhealthj.com/content/4/1/5
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sion is related to unhygienic practice. In this case
unhygienic practice involves the use of toilet water and
blood that has "gone off" in a syringe of extreme age.
The hygiene factor is also apparent in some participants'
misconception that it is possible to infect ones-self with
HCV through the re-use of one's own needle. In this case,
the hepatitis C virus is not viewed as an agent which is
external to the self, that is, it is caught from other people.
Rather hepatitis C infection is thought to result from the
"unclean" practice of re-using one's own needle. This mis-
conception is based on the belief that one's own blood,
once lodged in a used syringe, is capable of generating
HCV as it changes or "goes off". According to this folk
understanding, the health threat is endogenous to the
drug user's body rather than exogenous or external [30].
Reading the jaundiced body
Understandably, many participants were confused about
the differences between hepatitis A, hepatitis B, and hepa-
titis C. The most obvious sign of this was the description
participants gave of their own and others HCV serocon-
version illness. Numerous participants stated that they
"knew" they had contracted hepatitis C when they became
jaundiced. Unlike hepatitis A and hepatitis B, jaundice is
rarely associated with the acute phase of hepatitis C infec-
tion [31]. The commonly held assumption that hepatitis
C status can reliably be determined by symptomatic jaun-
dice has implications for prevention. In this case, infec-
tion and infectiousness is associated with a symptom that
is much more likely to occur in the acute phase of hepati-
tis A and hepatitis B infection, not HCV infection. Partici-
pants actively 'read' their own bodies and the bodies of
others, for jaundice. Jaundice was considered a reliable
sign on which to assess hepatitis C status and the subse-
quent risks in lending or borrowing injecting equipment.
Given the reliance some IDUs place on jaundice as a
marker of HCV infection and infectiousness means that
many may only seek HCV testing if they experience jaun-
dice. Also some may well be basing their assumed nega-
tive status on the fact that they have not experienced
jaundice. Michelle, a 35 year old injector, explains this
logic:
I mean, touch wood, I never got AIDS or anything like that,
and how I was diagnosed I was staying in a half-way house,
rehab type of thing...Once a week we'd do groups on women,
health issues and things like that and this one week was about
Hep C. And he (a doctor) said, 'Hands up the people that have
got it' and everyone put their hand up except for me and I said,
'Well, I've not been tested...but I can't remember being yellow
or anything like that."...He said 'You don't necessarily go yel-
low. Can you remember in the last five years having a really bad
flu?'
Everybody's antibodies: Folk understandings of clinical 
terms
Reading the interview data as a whole, there is the distinct
impression that many IDUs, at least half, were perplexed
about the implications of a hepatitis C diagnosis. Most, at
least two thirds, state that they are "carriers" who have
"cleared" the virus or that the virus is currently "dormant".
When asked about their current HCV status, over half of
the participants spoke of having "antibodies" but were
unsure what this meant in terms of their prognosis or their
ability to infect others. Approximately ten participants
recounted the fear and distress they felt after receiving a
positive diagnosis. The lack of adequate hepatitis C pre
and post test counselling has been documented in other
research [16,32]. The following interview revealed the
confusion and fear that can accompany a positive diagno-
sis:
I haven't got AIDS and I haven't got Hep B but what I was told
was that I carry the antibodies for (Hep) C, which I said
'What's that mean?'. Apparently it's that I might have a mild
case of it and don't have it any more...They still want to follow
it up now at the clinic and have a biopsy- cut a piece of my liver,
test my liver...I should have went back (to the clinic) but that
scared me. (Diane, a 29 year old injector).
Some participants, like Diane, spoke of having a "mild" or
"small" case of HCV. Other used the clinical term 'anti-
bodies' to describe having a resistance to HCV, somewhat
like acquiring antibodies after having chicken pox. For
example, Ken, a 22 year old injector, stated: "I've been
tested for Hep C. Been cleared and then the doctor said you got
antibodies against it and, then he said there's no sign of it in
your system." Another, Glen, a 30 year old who had shared
needles in jail, thought he was "one of those strange people
that might be able to fight it (hep C)", thus perpetually
avoiding infection. Phoebe, describes how proximity to
someone else's hepatitis B and hepatitis C antibodies pro-
vided protection for her:
I had a test...and they couldn't tell how me if I was a carrier or
whether I had hepatitis A years ago. I had a hep B test and they
said 'You're a carrier', and I said, 'Hang on, I've never had hep-
atitis in my life, never in my life.' 'Well', they said, 'you have
been close to someone who has antibodies and that's a good
thing'. I had a hep C test and they could only tell me the same
thing. (Phoebe, a 42 year old injector).
Only a few participants understood that although they
had spontaneously "cleared" the HCV, they were still
open to reinfection. Similarly, only a couple of partici-
pants demonstrated knowledge of superinfection, that is
infection with multiple genotypes of HCV. Confusion
around diagnostic explanations, such as 'antibodies
present' and 'virus cleared', left participants vulnerable toInternational Journal for Equity in Health 2005, 4:5 http://www.equityhealthj.com/content/4/1/5
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hepatitis C infection. These terms gave a false impression
that injectors were protected from reinfection and super-
infection because of the presence of antibodies.
Discussion
Marginalised IDUs experience a syndemic pattern of
health concerns, that is, they are affected by a set of syner-
gistic and mutually enhancing health and social problems
[33]. Public health concerns about hepatitis C should be
located within the syndemic nature of the health and wel-
fare issues facing marginalised people, such as those who
participated in this study. Within a syndemic context,
"risk" has myriad meanings, including but not solely
focused on, risks for the transmission of hepatitis C. While
the majority of participants were concerned about con-
tracting and transmitting hepatitis C, this concern was
only one of many which permeated everyday life. Hepati-
tis C did not have the immediacy of "the dreaded" HIV.
Infection with hepatitis C is common among IDUs'
friends and acquaintances. In the minds of IDUs, hepatitis
C infection offered an uncertain future, but unlike HIV, a
future none-the-less.
Indeed, hepatitis C was really the uncertain virus. For
many participants there was uncertainty about modes of
transmission other than through the sharing of needles.
Some participants blended blood awareness messages
with hygiene ones. This blending of messages created the
misconception that "dirty" behaviour and "dirty" people
were the cause of HCV infection. Participants were per-
plexed about the differences between the various hepatiti
and the symptoms of their acute phases. Confusion
accompanied hepatitis C diagnosis, with participants
actively reinterpreting the medical language of their diag-
nostic experience.
Lay people invariably read their bodies and the bodies of
others for signs of infection and illness [29,33]. So too do
they appropriate expert knowledge, including medical
terms and clinical markers, making sense of these at indi-
vidual and collective levels [34]. Sometimes medical
terms and clinical markers are actively used in the assess-
ment of risk practice [35]. Prevention efforts should con-
tinue to reiterate messages about the risks of sharing
needles and other injecting paraphernalia.
However prevention needs to be expanded to include
education about the hepatitis C virus itself. Clarification,
in accessible language, about the differences between the
hepatiti is required, in particular the fact that jaundice is
not a usual symptom of hepatitis C acute infection. The
IDUs in our study were using the symptom of jaundice as
a marker of infection and as a sign that they were capable
of infecting others. IDUs should be informed that jaun-
dice is not a reliable sign for gauging either infection or
infectiousness. Similarly they should be advised that they
should not wait for signs of jaundice before being tested
for HCV.
On the subject of HCV testing, the findings from this
study support other research [16,32] which suggests
improvements are needed in pre and post test counsel-
ling, and in the provision of long-term support and infor-
mation mechanisms for people with HCV, particularly
marginalised IDUs. Alleviating the fear surrounding the
testing experience and a positive HCV diagnosis is vital if
IDUs are to be encouraged to seek testing and treatment.
The participants in this study all frequented the Kings
Cross area where the range of drug services is the best in
Australia, yet these IDUs were still engaging in risk behav-
iour and were unsure about a number of issues around
hepatitis C. This suggests that even more support is
required for these people to change their behaviour. One
approach in Amsterdam has been the provision of case
managers who arrange housing, methadone treatment
and access to an injecting room for each client.
Moreover, the complexity of hepatitis infection, that is,
the possibility the virus can be spontaneously cleared and
the prospect of reinfection and superinfection, requires
explanation among this group. Professionally supported
peer education might be an efficient means of 'spreading
the word' about these matters [22,36]. Situating public
health certainties about the hepatitis C virus within the
context of marginalised injecting networks has proved a
challenging task. Targeted and accessible education and
health promotion messages are required to unravel the
complexities of HCV and its implications for acute and
chronic infection and infectiousness. On-going examina-
tion of folk understandings of medical terms and clinical
markers is a must if prevention and support efforts are to
be successful in controlling the HCV epidemic.
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